Stay updated on JNJ-77242113 in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the JNJ-77242113 in Psoriasis: Clinical Trial page.

Latest updates to the JNJ-77242113 in Psoriasis: Clinical Trial page
- Check3 days agoChange DetectedA new Locations section lists sites across multiple US states and Canadian provinces, and prior location subsections have been removed; this reorganizes how site availability is presented and where investigators can be contacted.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision label v3.3.2 was added and the previous v3.2.0 label removed; this is a maintenance update with no impact on the study information or page functionality.SummaryDifference0.0%

- Check40 days agoChange DetectedRemoved a non-essential notice about government funding and NIH operating status from the page. This does not affect the study details.SummaryDifference0.3%

- Check61 days agoChange DetectedNo substantive changes detected; updates appear limited to metadata and page formatting rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference3%

- Check90 days agoChange DetectedPage now shows Revision: v3.1.0 and removes several MedlinePlus drug safety topics and related MeSH terms, effectively narrowing content scope rather than adding new core information.SummaryDifference0.7%

Stay in the know with updates to JNJ-77242113 in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-77242113 in Psoriasis: Clinical Trial page.